Literature DB >> 21951286

Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture.

D S Yoon1, Y H Kim, H S Jung, S Paik, J W Lee.   

Abstract

OBJECTIVES: This study has aimed to repopulate 'primitive' cells from late-passage mesenchymal stem cells (MSCs) of poor multipotentiality and low cell proliferation rate, by simply altering plating density.
MATERIALS AND METHODS: Effects of low density culture compared t high density culture on late-passage bone marrow (BM)-derived MSCs and pluripotency markers of multipotentiality were investigated. Cell proliferation, gene expression, RNA interference and differentiation potential were assayed. RESULTS AND
CONCLUSIONS: We repopulated 'primitive' cells by replating late-passage MSCs at low density (17 cells/cm(2) ) regardless of donor age. Repopulated MSCs from low-density culture were smaller cells with spindle shaped morphology compared to MSCs from high-density culture. The latter had enhanced colony-forming ability, proliferation rate, and adipogenic and chondrogenic potential. Strong expression of osteogenic-related genes (Cbfa1, Dlx5, alkaline phosphatase and type Ι collagen) in late-passage MSCs was reduced by replating at low density, whereas expression of three pluripotency markers (Sox2, Nanog and Oct-4), Osterix and Msx2 reverted to levels of early-passage MSCs. Knockdown of Sox2 and Msx2 but not Nanog, using RNA interference, showed significant decrease in colony-forming ability. Specifically, knockdown of Sox2 significantly inhibited multipotentiality and cell proliferation. Our data suggest that plating density should be considered to be a critical factor for enrichment of 'primitive' cells from heterogeneous BM and that replicative senescence and multipotentiality of MSCs during in vitro expansion may be predominantly regulated through Sox2.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951286      PMCID: PMC6495637          DOI: 10.1111/j.1365-2184.2011.00770.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  55 in total

1.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells.

Authors:  B Johnstone; T M Hering; A I Caplan; V M Goldberg; J U Yoo
Journal:  Exp Cell Res       Date:  1998-01-10       Impact factor: 3.905

2.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

3.  Regulation of the pluripotency marker Rex-1 by Nanog and Sox2.

Authors:  Wenjing Shi; Hui Wang; Guangjin Pan; Yijie Geng; Yunqian Guo; Duanqing Pei
Journal:  J Biol Chem       Date:  2006-05-21       Impact factor: 5.157

4.  Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro.

Authors:  N Jaiswal; S E Haynesworth; A I Caplan; S P Bruder
Journal:  J Cell Biochem       Date:  1997-02       Impact factor: 4.429

5.  p21(cip1) rescues human mesenchymal stem cells from apoptosis induced by low-density culture.

Authors:  C van den Bos; S Silverstetter; M Murphy; T Connolly
Journal:  Cell Tissue Res       Date:  1998-09       Impact factor: 5.249

6.  Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Authors:  Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

7.  Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage.

Authors:  Andrea Dickhut; Karoliina Pelttari; Patricia Janicki; Wolfgang Wagner; Volker Eckstein; Marcus Egermann; Wiltrud Richter
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

8.  Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells.

Authors:  Michael B Mueller; Rocky S Tuan
Journal:  Arthritis Rheum       Date:  2008-05

9.  Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities.

Authors:  Masahiro J Go; Chiemi Takenaka; Hajime Ohgushi
Journal:  Exp Cell Res       Date:  2007-12-04       Impact factor: 3.905

10.  Replicative senescence of mesenchymal stem cells: a continuous and organized process.

Authors:  Wolfgang Wagner; Patrick Horn; Mirco Castoldi; Anke Diehlmann; Simone Bork; Rainer Saffrich; Vladimir Benes; Jonathon Blake; Stefan Pfister; Volker Eckstein; Anthony D Ho
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  54 in total

1.  NOTCH-Mediated Maintenance and Expansion of Human Bone Marrow Stromal/Stem Cells: A Technology Designed for Orthopedic Regenerative Medicine.

Authors:  Yufeng Dong; Teng Long; Cuicui Wang; Anthony J Mirando; Jianquan Chen; Regis J O'Keefe; Matthew J Hilton
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

2.  Density-Dependent Metabolic Heterogeneity in Human Mesenchymal Stem Cells.

Authors:  Yijun Liu; Nathalie Muñoz; Bruce A Bunnell; Timothy M Logan; Teng Ma
Journal:  Stem Cells       Date:  2015-08-14       Impact factor: 6.277

Review 3.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

4.  Characterization of adipose tissue-derived stromal vascular fraction for clinical application to cartilage regeneration.

Authors:  Yeonsue Jang; Yong Gon Koh; Yun-Jin Choi; Sung-Hwan Kim; Dong Suk Yoon; Moses Lee; Jin Woo Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-01       Impact factor: 2.416

5.  Characterization of different subpopulations from bone marrow-derived mesenchymal stromal cells by alkaline phosphatase expression.

Authors:  Yun Hee Kim; Dong Suk Yoon; Hyun Ok Kim; Jin Woo Lee
Journal:  Stem Cells Dev       Date:  2012-07-18       Impact factor: 3.272

6.  Defective proliferative potential of MSCs from pediatric myelodysplastic syndrome patients is associated with cell senescence.

Authors:  Qinghua Liu; Hongbo Zhu; Jing Dong; Helou Li; Hong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Development and gene expression of porcine cloned embryos derived from bone marrow stem cells with overexpressing Oct4 and Sox2.

Authors:  Jeong-Hyeon Lee; Won-Jae Lee; Ryoung-Hoon Jeon; Yeon-Mi Lee; Si-Jung Jang; Sung-Lim Lee; Byung-Geun Jeon; Sun-A Ock; W Allen King; Gyu-Jin Rho
Journal:  Cell Reprogram       Date:  2014-12       Impact factor: 1.987

8.  RNA-binding protein PUM2 regulates mesenchymal stem cell fate via repression of JAK2 and RUNX2 mRNAs.

Authors:  Myon-Hee Lee; Xinjun Wu; Yong Zhu
Journal:  J Cell Physiol       Date:  2019-10-09       Impact factor: 6.384

9.  Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells.

Authors:  Shuyun Wang; Lakshmi Mundada; Sean Johnson; Joshua Wong; Russell Witt; Richard G Ohye; Ming-Sing Si
Journal:  Stem Cells Transl Med       Date:  2015-02-23       Impact factor: 6.940

Review 10.  Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells.

Authors:  Darwin J Prockop
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.